Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.062 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |